Influenza and Other Respiratory Viruses

Papers
(The H4-Index of Influenza and Other Respiratory Viruses is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Respiratory syncytial virus disease burden in adults aged 60 years and older in high‐income countries: A systematic literature review and meta‐analysis149
COVID‐19 vaccine hesitancy and attitudes in Qatar: A national cross‐sectional survey of a migrant‐majority population122
Increased risk of rhinovirus infection in children during the coronavirus disease‐19 pandemic104
COVID‐19 severity from Omicron and Delta SARS‐CoV‐2 variants70
Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis64
Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID‐19 pandemic58
Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries57
The economic burden of influenza among adults aged 18 to 64: A systematic literature review54
Which influenza viruses will emerge following the SARS‐CoV‐2 pandemic?50
International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: Association with school closures44
Admission respiratory status predicts mortality in COVID‐1943
The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review43
The impact of the 2009 influenza pandemic on the seasonality of human respiratory syncytial virus: A systematic analysis36
Associations between persistent symptoms after mild COVID‐19 and long‐term health status, quality of life, and psychological distress35
Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults33
Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017–201930
Impact of coronavirus disease 2019 on respiratory surveillance and explanation of high detection rate of human rhinovirus during the pandemic in the Republic of Korea27
Using the health belief model to identify barriers to seasonal influenza vaccination among Australian adults in 201927
Transmission of SARS‐CoV‐2 during a 2‐h domestic flight to Okinawa, Japan, March 202027
The burden of seasonal influenza in Italy: A systematic review of influenza‐related complications, hospitalizations, and mortality25
Antibody responses to COVID‐19 vaccination in people with obesity: A systematic review and meta‐analysis25
Estimating the burden of adult hospital admissions due to RSV and other respiratory pathogens in England25
Global patterns of seasonal influenza activity, duration of activity and virus (sub)type circulation from 2010 to 202024
Impact of varying wave periods of COVID‐19 on in‐hospital mortality and length of stay for admission through emergency department: A territory‐wide observational cohort study23
0.044384002685547